[1]郝玉美,贺欣,宋娜玲.前列腺癌干细胞分离方法研究进展[J].国际放射医学核医学杂志,2013,37(5):296-300,305.[doi:10.3760/cma.j.issn.1673-4114.2013.05.011]
　HAO Yu-mei,HE Xin,SONG Na-ling.Advanced research on separating prostate cancer stem cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):296-300,305.[doi:10.3760/cma.j.issn.1673-4114.2013.05.011]
点击复制

前列腺癌干细胞分离方法研究进展(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
37
期数:
2013年第5期
页码:
296-300,305
栏目:
综述
出版日期:
2013-09-25

文章信息/Info

Title:
Advanced research on separating prostate cancer stem cells
作者:
郝玉美;  贺欣;  宋娜玲
300192 天津, 北京协和医学院中国医学科学院放射医学研究所, 天津市分子核医学重点实验室
Author(s):
HAO Yu-mei;  HE Xin;  SONG Na-ling
Tianjin Key Laboratory of Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin 300192, China
关键词:
前列腺癌; 前列腺癌干细胞; 分离
Keywords:
Prostate cancer; Prostate cancer stem cells; Separating
DOI:
10.3760/cma.j.issn.1673-4114.2013.05.011
摘要:
前列腺癌是男性泌尿系统中常见的恶性肿瘤,极易发展为激素难治性前列腺癌而难以治愈。近年来的研究认为前列腺癌干细胞是前列腺癌发生、发展、转移和复发的根源,针对前列腺癌干细胞的靶向治疗可能是根治前列腺癌的有效途径,但这些细胞所占比例极小,几乎难以检测到,目前的研究难点就在于前列腺癌干细胞的分离技术效率较低。故拟深入研究前列腺癌干细胞的功能,首先必须有效地分离前列腺癌干细胞。该文就目前前列腺癌干细胞的几种主要分离方法的研究进展及存在的问题进行综述,包括基于前列腺癌干细胞表面标志物的荧光激活细胞分选法、磁性激活细胞分选法和基于前列腺癌干细胞生物特性的侧群细胞筛选法、体外无血清聚球筛选法。
Abstract:
Prostate cancer is a common malignant tumor in male urinary system, and may easyly develope into the hormone refractory prostate cancer which can hardly be cured.Recent studies had found that the prostate cancer stem cells may be the source of the prostate cancer’s occurrence, development, metastasis and recurrence.The therapy targeting the prostate cancer stem cells may be the effective way to cure prostate cancer.But these cells is too low to be detected.The difficulty lies in the low separation efficiency of prostate cancer stem cell, so the effectively separating prostate cancer stem cells occupied the main position for the more in-depth research of prostate cancer stem cells.This paper reviews the research progress and existing problems on the several main separating methods of prostate cancer stem cells, includes the fluorescence activated cells sorting and magnetic activated cells sorting based on prostate cancer stem cell surface markers, the side-population sorting and serum-free medium sphere forming sorting based on prostate cancer stem cell’s biology.

参考文献/References:

[1] Boorjian SA, Karnes RJ, Viterbo R, et al. Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer. Cancer, 2011, 117(13):2883-2891.
[2] Rajasekhar VK, Studer L, Gerald W, et al. Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappa B signalling. Nat Commun, 2011,2:162.
[3] Kasper S, Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens. Urol Oncol,2009,27(3):301-303.
[4] Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem oells. Nature, 2001, 414(6859):105-111.
[5] Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells-perspectives on current status and future directions:AACR workshop on cancer stem cells. Cancer Res, 2006, 66(19):9339-9344.
[6] Patrawala L, Calhoun-Davis T, Schneider-Broussard R, et al.Hierarchical organization of prostate cancer cells in xenograft tumors:the CD44+α2β1+ cell population is enriched in tumor-initiating cells. Cancer Res, 2007,67(14):6796-6805.
[7] Yu C, Yao Z, Jiang Y, et al. Prostate cancer stem cell biology.Minerva Urol Nefrol, 2012, 64(1):19-33.
[8] Goldstein AS, Huang J, Guo C, et al. Identification of a cell of origin for human prostate cancer. Science, 2010,329(5991):568-571.
[9] Wang W, Eddy R, Condeelis J. The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer, 2007, 7(6):429-440.
[10] Wang G, Wang Z, Sarkar FH, et al. Targeting prostate cancer stem cells for cancer therapy. Discov Med, 2012, 13(69):135-142.
[11] O’Donnell EA, Ernst DN, Hingorani R. Multiparameter flow cytometry:advances in high resolution analysis. Immune Netw,2013,13(2):43-54.
[12] Sidani M, Wessels D, Mouneimne G, et al. Cofilin determines the migration behavior and turning frequency of metastatic cancer cells.JCell Biol, 2007, 179(4):777-791.
[13] Maitland NJ, Collins AT. Prostate cancer stem cells:a new target for therapy. J Clin Oncol, 2008,26(17):2862-2870.
[14] Liu T, Xu F, Du X, et al. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1. Mol Cell Biochem,2010,340(1-2):265-273.
[15] Patrawala L, Calhoun T, Schneider-Broussard R, et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Onco-gene, 2006, 25(12):1696-1708.
[16] Jiao J, Hindoyan A, Wang S, et al. Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells. PLoS One, 2012, 7(8):e42564[2013-06-08].http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0042564.
[17] Sheng X,Li Z, Wang DL, et al. Isolation and enrichment of PC-3 prostate cancer stem-like cells using MACS and serum-free medium. Oncol Lett, 2013, 5(3):787-792.
[18] Castellón EA, Valenzuela R, Lillo J, et al. Molecular signature of cancer stem cells isolated from prostate carcinoma and expression of stem markers in different Gleason grades and metastasis. Biol Res, 2012,45(3):297-305.
[19] 耿珊,张琛,刘俊,等.免疫磁性活化细胞分选方法优化及纯化后细胞的生物学特性检测.细胞与分子免疫学杂志,2012,28(7):752-754.
[20] Schriebl K, Satianegara G, Hwang A, et al. Selective removal of undifferentiated human embryonic stem cells using magnetic activated cell sorting followed by a cytotoxic antibody. Tissue Eng Part A, 2012, 18(9-10):899-909.
[21] 罗勇,崔新浩,姜永光,等.细胞株源人前列腺肿瘤干细胞的分选与鉴定.中华男科学杂志,2012,18(12):1062-1068.
[22] 殷波,刘岗,张辉,等.人前列腺癌细胞系DU 145中肿瘤干细胞样侧群细胞的分离.现代肿瘤医学,2012,20(6):1110-1112.
[23] Chen Y, Zhao J, Luo Y, et al. Isolation and identification of cancer stem-like cells from side population of human prostate cancer cells.J Huazhong Univ Sci Technolog Med Sci, 2012, 32(5):697-703.
[24] Platet N, Mayol JF, Berger F, et al. Fluctuation of the SP/non-SP phenotype in the C6 glioma cell line. FEBS Lett, 2007,581(7):1435-1440.
[25] 钟永,张叔人.侧群细胞与肿瘤干细胞研究进展.中华肿瘤防治杂志,2008(24):1914-1918.
[26] Fan X, Liu S, Su F, et al. Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system. Urol Oncol,2012,30(3):314-318.
[27] Zhang L, Jiao M, Li L, et al. Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.J Cancer Res Clin Oncol, 2012,138(4):675-686.
[28] 张波,范新兰,林天歆,等.人PC-3细胞系中前列腺癌干细胞的富集与鉴定.中山大学学报:医学科学版,2010,31(6):878-883.
[29] 李奎庆,许可慰,周邦奋,等.前列腺癌干细胞分离方法的对比及筛选.中国组织工程研究,2012,16(6):1011-1014.

相似文献/References:

[1]秦岚.前列腺癌近距离放射治疗的进展[J].国际放射医学核医学杂志,2005,29(4):159.
　QIN Lan.Evolution of brachytherapy for prostate carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):159.
[2]廖安燕,王俊杰.持续低剂量率照射治疗前列腺癌的生物学效应[J].国际放射医学核医学杂志,2005,29(4):190.
　LIAO An-yan,WANG Jun-jie.The biological effect of continuous low-dose rate irradiation for prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):190.
[3]王俊杰.放射性粒子近距离治疗前列腺癌:临床篇[J].国际放射医学核医学杂志,2002,26(3):101.
　WANG Jun-jie.Radioactive seed implantation treatment for prostate carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(5):101.
[4]王宇.间质植入近距离照射治疗前列腺癌[J].国际放射医学核医学杂志,2001,25(5):233.
　WANG Yu.Interstitial implantation brachytherapy for the treatment of prostate carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(5):233.
[5]陈立波.钠/碘同向转运体与放射性碘治疗[J].国际放射医学核医学杂志,2001,25(6):258.
　CHEN Li-bo.The sodium/iodide symporter and radioiodide therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(5):258.
[6]许杨.前列腺特异性抗原及其临床应用[J].国际放射医学核医学杂志,2000,24(5):201.
　XU Yang.Prostate specific antigen and its clinical apptication[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(5):201.
[7]陆汉魁,林祥通,刘家慧,等.乳腺癌和前列腺癌的类固醇受体显像研究现状[J].国际放射医学核医学杂志,1996,20(3):106.

备注/Memo

备注/Memo:
收稿日期:2013-06-08。
基金项目:国家自然科学基金面上项目(81272511);中国医学科学院放射医学研究所探索基金(ST1313)
通讯作者:宋娜玲,Email:nalingsong@sina.com
更新日期/Last Update: 1900-01-01